No abstract available
MeSH terms
-
Adenocarcinoma / drug therapy*
-
Adenocarcinoma / pathology
-
Adenocarcinoma of Lung
-
Antibodies, Monoclonal, Humanized / administration & dosage
-
Antibodies, Monoclonal, Humanized / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Bevacizumab
-
Carboplatin / administration & dosage
-
Carboplatin / adverse effects
-
Humans
-
Ichthyosis / chemically induced*
-
Lung Neoplasms / drug therapy*
-
Lung Neoplasms / pathology
-
Male
-
Middle Aged
-
Tumor Lysis Syndrome / etiology*
Substances
-
Antibodies, Monoclonal, Humanized
-
Bevacizumab
-
Carboplatin